104 related articles for article (PubMed ID: 3249326)
1. Recalcification time in breast disease.
Sofia CA; Spillert CR; Pastena JA; Lazaro EJ
J Natl Med Assoc; 1988 Nov; 80(11):1214-6. PubMed ID: 3249326
[TBL] [Abstract][Full Text] [Related]
2. Assessment of monocyte function in breast disease.
Spillert CR; Curtis GT; Lazaro EJ
South Med J; 1988 Feb; 81(2):164-6. PubMed ID: 3277286
[TBL] [Abstract][Full Text] [Related]
3. Procoagulant activity in whole blood from patients with breast and colorectal cancer.
Parmar J; Taylor I; Roath S; Francis J
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):127-32. PubMed ID: 2130924
[TBL] [Abstract][Full Text] [Related]
4. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
England PC; Sellwood RA; Knyba RE; Irvine JD
Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
[No Abstract] [Full Text] [Related]
5. Hypercoagulability in arterial disease.
Spillert CR; Milazzo VJ; Suval WD; Lazaro EJ
Angiology; 1989 Oct; 40(10):886-9. PubMed ID: 2802258
[TBL] [Abstract][Full Text] [Related]
6. Shortened endotoxin-activated clotting times in patients with carcinoma.
Spillert CR; Lazaro EJ
Am Surg; 1987 Mar; 53(3):164-6. PubMed ID: 3548512
[TBL] [Abstract][Full Text] [Related]
7. A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast.
Thynne GS; Greening WP
Clin Oncol; 1980 Dec; 6(4):317-21. PubMed ID: 7460405
[No Abstract] [Full Text] [Related]
8. Monocyte tissue factor levels in cancer patients.
Lwaleed BA; Francis JL; Chisholm M
Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
[TBL] [Abstract][Full Text] [Related]
9. Detection of placental protein five (PP5) and pregnancy-specific glycoprotein (SP1) in benign and malignant breast disease.
Bremner RD; Nisbet AD; Herriot R; Horne CH; McArdle C; Crawford D; Bohn H
Oncodev Biol Med; 1981; 2(1-2):55-62. PubMed ID: 6975467
[TBL] [Abstract][Full Text] [Related]
10. Whole blood procoagulant activity in breast and colorectal cancer.
Mellor H; Taylor I; Roath S; Francis JL
J Clin Pathol; 1989 May; 42(5):489-94. PubMed ID: 2732342
[TBL] [Abstract][Full Text] [Related]
11. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
[TBL] [Abstract][Full Text] [Related]
12. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
[TBL] [Abstract][Full Text] [Related]
13. Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease.
Schrauzer GN; Molenaar T; Mead S; Kuehn K; Yamamoto H; Araki E
Jpn J Cancer Res; 1985 May; 76(5):374-7. PubMed ID: 3924710
[TBL] [Abstract][Full Text] [Related]
14. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)].
Bischoff J; Rebhan EM; Prestele H; Becker H
Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):65-71. PubMed ID: 7353778
[TBL] [Abstract][Full Text] [Related]
15. Altered coagulability: an aid to selective breast biopsy.
Spillert CR; Passannante MR; Salzer-Pagan JE; Lazaro EJ
J Natl Med Assoc; 1993 Apr; 85(4):273-7. PubMed ID: 8478968
[TBL] [Abstract][Full Text] [Related]
16. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
[TBL] [Abstract][Full Text] [Related]
17. Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes.
Osterud B; Due J
Scand J Haematol; 1984 Mar; 32(3):258-64. PubMed ID: 6199833
[TBL] [Abstract][Full Text] [Related]
18. High performance liquid chromatographic determination of serum UV profiles of normal subjects and patients with breast cancer and benign fibrocystic changes.
Krstulovic AM; Hartwick RA; Brown PR
Clin Chim Acta; 1979 Oct; 97(2-3):159-70. PubMed ID: 487602
[TBL] [Abstract][Full Text] [Related]
19. Endotoxin-induced procoagulant activity in equine peripheral blood monocytes.
Henry MM; Moore JN
Circ Shock; 1988 Nov; 26(3):297-309. PubMed ID: 3208423
[TBL] [Abstract][Full Text] [Related]
20. Altered monocyte function in patients with benign breast disease.
Al-Sumidaie AM; Leinster SJ; Jenkins SA
Clin Exp Immunol; 1987 Jan; 67(1):198-204. PubMed ID: 3621673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]